USPTO serial 90765846
ARISTADA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 16, 2022
- Examiner
- GRIFFIS, SAVANNAH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ARISTADA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Alkermes Pharma Ireland Limited
Dublin 4, IE
Alkermes Pharma Ireland Limited
Dublin 4, IE
Alkermes Pharma Ireland Limited
Dublin 4, IE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Norm J. Rich
NORM J. RICH FOLEY & LARDNER LLP3000 K STREET, N.W.SIXTH FLOORWASHINGTON, DC 20007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Logistics management in the field of medication, namely, business services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical services, namely, providing information about pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms; appointment reminder services being support services for patients and for health care providers on behalf of their patients | ACTIVE | Oct 5, 2015 |
| 036 | Providing information about pharmacies, namely, providing a database featuring information about insurance coverage for pharmaceuticals in the nature of pharmacy selection based on patient health plan coverage requirements; providing information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance services being support services for patients and for health care providers on behalf of their patients, namely, providing health benefit verification services to determine coverage of medication treatment; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patients, namely, coordinating medication reimbursement programs | ACTIVE | Oct 5, 2015 |
| 044 | Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about the diagnostic, prophylactic, and therapeutic properties of pharmaceuticals and pharmaceutical products for medical purposes | ACTIVE | Oct 5, 2015 |
| 045 | Support services for health care providers and their patients in the nature of providing patient advocate and case management services, namely, coordinating the procurement of medication in the nature of coordinating with pharmacies to facilitate prescription fulfillment; providing patient advocate and case management services in the nature of support services for patients and for health care providers on behalf of their patients, namely, coordinating the procurement and administration of medication in the nature of locating health care providers that can prescribe and administer prescribed medication | ACTIVE | Oct 5, 2015 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Alkermes Pharma Ireland Limited
- Other trademarks owned by Alkermes Pharma Ireland Limited
- Other trademarks owned by Alkermes Pharma Ireland Limited
- Other trademarks in Class 035
- Other trademarks in Class 036
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named ARISTADA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 24, 2026 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Aug 16, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 16, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 31, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 31, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 11, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 26, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 26, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 26, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 26, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 26, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 15, 2022 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 29, 2022 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Mar 15, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 14, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 14, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 1, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 30, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 14, 2021 | NWAP | NEW APPLICATION ENTERED | — |